358 related articles for article (PubMed ID: 9407422)
1. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
[TBL] [Abstract][Full Text] [Related]
2. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
[TBL] [Abstract][Full Text] [Related]
3. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
4. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.
Ruggenenti P; Perna A; Gherardi G; Gaspari F; Benini R; Remuzzi G
Lancet; 1998 Oct; 352(9136):1252-6. PubMed ID: 9788454
[TBL] [Abstract][Full Text] [Related]
5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
6. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
Ruggenenti P; Perna A; Remuzzi G;
Kidney Int; 2003 Jun; 63(6):2254-61. PubMed ID: 12753315
[TBL] [Abstract][Full Text] [Related]
7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
[TBL] [Abstract][Full Text] [Related]
9. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
[TBL] [Abstract][Full Text] [Related]
10. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
11. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
13. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.
Ruggenenti P; Perna A; Benini R; Bertani T; Zoccali C; Maggiore Q; Salvadori M; Remuzzi G
J Am Soc Nephrol; 1999 May; 10(5):997-1006. PubMed ID: 10232685
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.
Imbasciati E; Gregorini G; Cabiddu G; Gammaro L; Ambroso G; Del Giudice A; Ravani P
Am J Kidney Dis; 2007 Jun; 49(6):753-62. PubMed ID: 17533018
[TBL] [Abstract][Full Text] [Related]
15. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.
Jungers P; Hannedouche T; Itakura Y; Albouze G; Descamps-Latscha B; Man NK
Nephrol Dial Transplant; 1995; 10(8):1353-60. PubMed ID: 8538926
[TBL] [Abstract][Full Text] [Related]
16. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
Jones C; Roderick P; Harris S; Rogerson M
Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
[TBL] [Abstract][Full Text] [Related]
17. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
18. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen).
Ruggenenti P; Perna A; Zoccali C; Gherardi G; Benini R; Testa A; Remuzzi G
J Am Soc Nephrol; 2000 Jan; 11(1):88-96. PubMed ID: 10616844
[TBL] [Abstract][Full Text] [Related]
19. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
Ardissino G; Viganò S; Testa S; Daccò V; Paglialonga F; Leoni A; Belingheri M; Avolio L; Ciofani A; Claris-Appiani A; Cusi D; Edefonti A; Ammenti A; Cecconi M; Fede C; Ghio L; La Manna A; Maringhini S; Papalia T; Pela I; Pisanello L; Ratsch IM;
Nephrol Dial Transplant; 2007 Sep; 22(9):2525-30. PubMed ID: 17526542
[TBL] [Abstract][Full Text] [Related]
20. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
Kamper AL; Strandgaard S; Leyssac PP
Nephrol Dial Transplant; 1995; 10(7):1182-8. PubMed ID: 7478121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
